The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE: Next phase of UK vaccine programme begins as over-45s get jabs

Tue, 13th Apr 2021 12:55

(Alliance News) - The UK National Health Service has invited people over the age of 45 to book their Covid-19 vaccine appointment.

It signals the start of "Phase 2" of the vaccination programme – which involves offering vaccines to healthy adults aged under 50.

The move comes as it was announced that the government has met its target of offering the vaccine to all adults over the age of 50.

In England it has been estimated that 19 in 20 of those who have already been offered the jab have taken up the offer.

One vaccination expert said that it was "vitally important" to vaccinate "the last few percent", or they could get infected and end up in hospital.

Jeremy Brown, from University College London Hospitals and member of the Joint Committee of Vaccination & Immunisation, told the Today programme: "The problem here is that 5% to 10% have not been vaccinated.

"When the virus re-circulates through the community they could get infected and end up in hospital.

"So it's vitally important that we get that last few percent."

Until now, the NHS had been focusing on offering vaccines to those deemed to be at highest risk – people over the age of 50, those deemed to be "clinically extremely vulnerable" and health and social care workers.

When its online booking system opened up to include people over the age of 45, the website crashed for many.

The announcement comes despite an earlier warning by the NHS in England of a "significant reduction in weekly supply" during April, meaning volumes for first doses would be "significantly constrained".

The prime minister hailed the "hugely significant milestone" in the vaccination programme of reaching the April 15 target.

In a statement, UK Prime Minister Boris Johnson said that the government remained on course to offer a first jab to all adults in the UK by the end of July.

"We have now passed another hugely significant milestone in our vaccine programme by offering jabs to everyone in the nine highest risk groups," he said.

"That means more than 32 million people have been given the precious protection vaccines provide against Covid 19.

"I want to thank everyone involved in the vaccine rollout which has already saved many thousands of lives.

"We will now move forward with completing essential second doses and making progress towards our target of offering all adults a vaccine by the end of July."

The news comes as the Moderna vaccine was used for the first time in England.

The government has ordered 17 million doses of the jab – enough for 8.5 million people.

Meanwhile, Ireland became the latest country to restrict the use of the AstraZeneca PLC vaccine, saying it should not be given to people under the age of 60, amid concerns over possible links to rare blood clotting events.

In the UK, the advice is that it should not be administered to those aged under 30.

In all, the government said almost 40 million doses of the Pfizer Inc and AstraZeneca vaccines have been delivered since the rollout began in the UK in December, including 32 million first jabs and more than seven million second doses.

NHS England chief executive Simon Stevens said 19 out of 20 over-50s had now received a first jab.

"Thanks to our NHS nurses, doctors, pharmacists, operational managers and thousands of other staff and volunteers, the NHS Covid vaccination programme is without a doubt the most successful in our history," he said.

"It's one of our tickets out of this pandemic and offers real hope for the future."

Throughout the current month, the health service has prioritised second doses of the Pfizer and AstraZeneca vaccines with a record 475,230 people receiving their second jab on Saturday.

Meanwhile, there will be a surge in testing in the boroughs of Lambeth and Wandsworth in south London following the identification of a number of cases of a variant of the virus first found in South Africa.

Dozens of people were told to isolate after the Department for Health and Social Care said there had been 44 confirmed cases of the strain, with a further 30 suspected.

It came as scenes posted on social media showed revellers gathering in Soho, central London, following the latest easing of lockdown restrictions in England, prompting fears that social distancing guidelines were being ignored.

By Ella Pickover, PA Health Correspondent

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.